AKCEA THERAPEUTICS, INC.
AKCEA THERAPEUTICS, INC. (AKCA) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 70 transactions totaling $614.0M, demonstrating a bullish sentiment with $606.9M in net insider flow. The most recent transaction on Oct 12, 2020 involved a transaction of 242,978 shares valued at $4.4M.
AKCA Insider Activity Summary
Who Is Buying AKCA Stock?
No significant insider buying has been recorded for AKCA in the recent period.
Who Is Selling AKCA Stock?
No significant insider selling has been recorded for AKCA in the recent period.
Is AKCEA THERAPEUTICS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AKCA is bullish with an Insider Alignment Score of 99/100 and a net flow of $606.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AKCA Frequently Asked Questions
Understanding AKCA Insider Activity
Insider trading at AKCEA THERAPEUTICS, INC. (AKCA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading AKCA stock, having executed 70 transactions in the past 90 days. The most active insider is Pharmaceuticals Inc Ionis (Executive), who has made 10 transactions totaling $610.5M.
Related Tools
Track AKCEA THERAPEUTICS, INC. Insider Activity
Get notified when executives and directors at AKCA file new Form 4 transactions